Customer Concentration

Integrated BioPharma (INBP) reported its Q3 2025 financial results, revealing a 6.6% revenue decrease to $12.7 million compared to Q3 2024. Gross profit, operating income, and net income also declined. A significant concern is the high customer concentration, with the top two clients accounting for approximately 87% of revenue, up from 85% in the prior year. Despite decreased revenue and profits, INBP still maintained a net income of $0.12 million, or $0.00 diluted per share.

Oracle shares dipped 7% following a record high, driven by concerns over reliance on OpenAI, potentially committing $300 billion over five years. This news followed strong first-quarter results, fueled by multi-billion-dollar contracts and a 359% surge in remaining performance obligation to $455 billion. Oracle forecasts a 14-fold cloud infrastructure revenue expansion by 2030 to support AI. Analysts worry about the sustainability of Oracle’s revenue, highlighting risk concentration and the importance of diversification in the competitive cloud market.